These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 11025458)
1. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. Zang RY; Zhang ZY; Li ZT; Chen J; Tang MQ; Liu Q; Cai SM J Surg Oncol; 2000 Sep; 75(1):24-30. PubMed ID: 11025458 [TBL] [Abstract][Full Text] [Related]
2. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649 [TBL] [Abstract][Full Text] [Related]
3. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC). Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175 [TBL] [Abstract][Full Text] [Related]
5. Secondary cytoreductive surgery in recurrent epithelial ovarian cancer: A prognostic analysis with 103 cases. Fan XM; Zhang J; Niu SH; Li KX; Song CZ Int J Surg; 2017 Feb; 38():61-66. PubMed ID: 28027999 [TBL] [Abstract][Full Text] [Related]
6. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy. Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820 [TBL] [Abstract][Full Text] [Related]
7. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603 [TBL] [Abstract][Full Text] [Related]
8. [Factors affecting disease recurrence and the role of secondary therapies in the management for patients with recurrent ovarian carcinoma]. Zang R; Zhang Z; Cai S Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):546-9. PubMed ID: 12411017 [TBL] [Abstract][Full Text] [Related]
9. Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer. Felsinger M; Minar L; Weinberger V; Rovny I; Zlamal F; Bienertova-Vasku J Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():154-160. PubMed ID: 29957400 [TBL] [Abstract][Full Text] [Related]
10. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer]. Li YF; Li MD; Liu FY; Liu JH; Li JD Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651 [TBL] [Abstract][Full Text] [Related]
11. Surgery and salvage chemotherapy for Chinese women with recurrent advanced epithelial ovarian carcinoma: a retrospective case-control study. Zang RY; Li ZT; Zhang ZY; Cai SM Int J Gynecol Cancer; 2003; 13(4):419-27. PubMed ID: 12911717 [TBL] [Abstract][Full Text] [Related]
12. Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: implications for tertiary cytoreductive surgery. Tang J; Liu DL; Shu S; Tian WJ; Liu Y; Zang RY Eur J Surg Oncol; 2013 Jul; 39(7):786-91. PubMed ID: 23490332 [TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of secondary cytoreductive surgery for recurrent advanced ovarian cancer]. Zang R; Zhang Z; Cai S Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):194-6. PubMed ID: 12015048 [TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery for stage IV epithelial ovarian cancer. Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968 [TBL] [Abstract][Full Text] [Related]
15. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134 [TBL] [Abstract][Full Text] [Related]